| HGNC Family | Non-coding RNAs |
| Name | microRNA 425 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent studies have revealed that miR‐425 (including both its –3p and –5p isoforms) plays multifaceted roles in tumorigenesis. In several cancers, including breast, gastric, colorectal, esophageal, cervical, prostate, hepatocellular, renal, osteosarcoma, glioblastoma, and ovarian carcinomas, miR‐425 can act either as an oncogene or as a tumor‐suppressive factor depending on cellular context. For instance, the miR‐191/425 cluster is estrogen‐responsive in breast cancer and contributes to the regulation of proliferation, apoptosis, and metastasis by targeting key tumor suppressors such as PTEN, FOXD3, PDCD10, and SMAD2; similarly, in colorectal, gastric, and esophageal cancers, aberrant miR‐425 expression is linked to chemoresistance and enhanced malignant behavior through modulation of downstream effectors. Moreover, studies in prostate cancer and hepatocellular carcinoma have demonstrated that miR‐425 upregulation correlates with poor prognosis and chemoresistance, while its dysregulation in clear cell renal carcinoma, laryngeal carcinoma, and KRAS‐mutated colorectal cancer further underscores its pivotal function in dictating tumor aggressiveness and therapeutic response."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "24"}, {"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond cancer, miR‐425 also exerts significant effects in cardiovascular and neurological settings. Notably, in the heart, miR‐425 regulates the production of atrial natriuretic peptide by binding to NPPA mRNA in an allele‐specific manner, thereby influencing blood pressure and responses to salt overload. In the central nervous system, miR‐425 deficiency has been implicated in promoting necroptosis of dopaminergic neurons—a process linked to the pathogenesis of Parkinson’s disease—and has also been associated with differential expression in the context of antidepressant treatment response, suggesting neuromodulatory as well as vascular roles mediated via NF‑κB–dependent pathways."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "25", "end_ref": "28"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition, miR‐425 is emerging as an important modulator of immune responses and aging. Elevated miR‐425 expression in T helper 17 cells has been shown to promote pathogenic differentiation in inflammatory bowel disease through targeting Foxo1, whereas reduced levels of miR‐425 in centenarians and patients with rheumatoid arthritis suggest a possible role in mediating immune homeostasis and longevity."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "29"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Gianpiero Di Leva, Claudia Piovan, Pierluigi Gasparini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Genet (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pgen.1003311"}], "href": "https://doi.org/10.1371/journal.pgen.1003311"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23505378"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23505378"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Jun Ma, Jun Liu, Zhiming Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NF-kappaB-dependent microRNA-425 upregulation promotes gastric cancer cell growth by targeting PTEN upon IL-1β induction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1476-4598-13-40"}], "href": "https://doi.org/10.1186/1476-4598-13-40"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24571667"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24571667"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Patryk Moskwa, Pascal O Zinn, Young Eun Choi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A functional screen identifies miRs that induce radioresistance in glioblastomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1541-7786.MCR-14-0268"}], "href": "https://doi.org/10.1158/1541-7786.MCR-14-0268"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25256711"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25256711"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Pei Liu, Yaotian Hu, Ling Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-425 inhibits melanoma metastasis through repression of PI3K-Akt pathway by targeting IGF-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2015.08.010"}], "href": "https://doi.org/10.1016/j.biopha.2015.08.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26463631"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26463631"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Ye Zhang, Xingqian Hu, Xiaofei Miao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-425-5p regulates chemoresistance in colorectal cancer cells via regulation of Programmed Cell Death 10."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.12742"}], "href": "https://doi.org/10.1111/jcmm.12742"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26647742"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26647742"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Lingyan Liu, Zitong Zhao, Wei Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Enhanced Expression of miR-425 Promotes Esophageal Squamous Cell Carcinoma Tumorigenesis by Targeting SMAD2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Genet Genomics (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jgg.2015.09.010"}], "href": "https://doi.org/10.1016/j.jgg.2015.09.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26674378"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26674378"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Yanfang Gao, Yuzhu Yin, Xiumei Xing, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Arsenic-induced anti-angiogenesis via miR-425-5p-regulated CCM3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Toxicol Lett (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.toxlet.2016.04.023"}], "href": "https://doi.org/10.1016/j.toxlet.2016.04.023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27132035"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27132035"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Liwei Sun, Rong Jiang, Jinduo Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Clin Biochem (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/0004563216649377"}], "href": "https://doi.org/10.1177/0004563216649377"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27166306"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27166306"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Mingxia Zhu, Zebo Huang, Danxia Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A panel of microRNA signature in serum for colorectal cancer diagnosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.15059"}], "href": "https://doi.org/10.18632/oncotarget.15059"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28177881"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28177881"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Feng Fang, Tianqiang Song, Ti Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathways."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.15958"}], "href": "https://doi.org/10.18632/oncotarget.15958"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28423650"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28423650"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Y-F Yan, F-M Gong, B-S Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-425-5p promotes tumor progression via modulation of CYLD in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2017)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28537672"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28537672"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Q Cai, A Zhao, L-G Ren, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-425 involves in the development and progression of renal cell carcinoma by inhibiting E2F6."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201810_16040"}], "href": "https://doi.org/10.26355/eurrev_201810_16040"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30338798"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30338798"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "J-Y Zhang, X-P Su, Y-N Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-425-5p promotes the development of prostate cancer via targeting forkhead box J3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201901_16867"}], "href": "https://doi.org/10.26355/eurrev_201901_16867"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30720162"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30720162"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Guohui Yang, Chi Zhang, Nan Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-425-5p decreases LncRNA MALAT1 and TUG1 expressions and suppresses tumorigenesis in osteosarcoma via Wnt/β-catenin signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biochem Cell Biol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biocel.2019.04.004"}], "href": "https://doi.org/10.1016/j.biocel.2019.04.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30986552"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30986552"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Zhennan Yuan, Cheng Xiu, Daming Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA LINC-PINT regulates laryngeal carcinoma cell stemness and chemoresistance through miR-425-5p/PTCH1/SHH axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.28874"}], "href": "https://doi.org/10.1002/jcp.28874"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31131448"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31131448"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Sheng Liu, Qin Wang, Yin Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-425-5p suppresses tumorigenesis and DDP resistance in human-prostate cancer by targeting GSK3β and inactivating the Wnt/β-catenin signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biosci (2019)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31502580"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31502580"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Sheng Xiao, Hongjia Zhu, Jian Luo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR‑425‑5p is associated with poor prognosis in patients with breast cancer and promotes cancer cell progression by targeting PTEN."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2019.7371"}], "href": "https://doi.org/10.3892/or.2019.7371"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31638259"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31638259"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Andrea Angius, Giovanna Pira, Antonio Mario Scanu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-425-5p Expression Affects BRAF/RAS/MAPK Pathways In Colorectal Cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Med Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/ijms.35269"}], "href": "https://doi.org/10.7150/ijms.35269"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31673240"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31673240"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Lei Jiang, Wenyu Ge, Jingshu Geng "}, {"type": "b", "children": [{"type": "t", "text": "miR-425 regulates cell proliferation, migration and apoptosis by targeting AMPH-1 in non-small-cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Res Pract (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.prp.2019.152705"}], "href": "https://doi.org/10.1016/j.prp.2019.152705"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31685299"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31685299"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Dan Rao, Songmei Guan, Junwei Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-425-5p Acts as a Molecular Marker and Promoted Proliferation, Migration by Targeting RNF11 in Hepatocellular Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Res Int (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2020/6530973"}], "href": "https://doi.org/10.1155/2020/6530973"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33123581"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33123581"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Haohao Li, Chunlin Zhao, Hongchao Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Elevated linc00936 or silenced microRNA-425-3p inhibits immune escape of gastric cancer cells via elevation of ZC3H12A."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int Immunopharmacol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.intimp.2021.107559"}], "href": "https://doi.org/10.1016/j.intimp.2021.107559"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33756228"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33756228"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Michele Patrícia Rode, Adny Henrique Silva, Júlia Cisilotto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-425-5p as an exosomal biomarker for metastatic prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Signal (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellsig.2021.110113"}], "href": "https://doi.org/10.1016/j.cellsig.2021.110113"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34371055"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34371055"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Yinling Zhao, Donglan Yuan, Dandan Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Ovarian Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13048-021-00857-2"}], "href": "https://doi.org/10.1186/s13048-021-00857-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34454554"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34454554"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Anwen Liu, Wenxia Pan, Shutong Zhuang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cancer cell-derived exosomal miR-425-3p induces white adipocyte atrophy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Adipocyte (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21623945.2022.2108558"}], "href": "https://doi.org/10.1080/21623945.2022.2108558"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35941833"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35941833"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Pankaj Arora, Connie Wu, Abigail May Khan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Atrial natriuretic peptide is negatively regulated by microRNA-425."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI67383"}], "href": "https://doi.org/10.1172/JCI67383"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23867623"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23867623"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Juan Pablo Lopez, Laura M Fiori, Cristiana Cruceanu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms15497"}], "href": "https://doi.org/10.1038/ncomms15497"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28530238"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28530238"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Yong-Bo Hu, Yong-Fang Zhang, Hao Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-019-1809-5"}], "href": "https://doi.org/10.1038/s41419-019-1809-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31383850"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31383850"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Erfei Luo, Dong Wang, Gaoliang Yan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The NF-κB/miR-425-5p/MCT4 axis: A novel insight into diabetes-induced endothelial dysfunction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Endocrinol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.mce.2019.110641"}], "href": "https://doi.org/10.1016/j.mce.2019.110641"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31711985"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31711985"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Francesca Balzano, Marta Deiana, Silvia Dei Giudici, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA Expression Analysis of Centenarians and Rheumatoid Arthritis Patients Reveals a Common Expression Pattern."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Med Sci (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/ijms.18972"}], "href": "https://doi.org/10.7150/ijms.18972"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28824293"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28824293"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Xue Yang, Qinyu He, Zhenzhen Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-425 facilitates pathogenic Th17 cell differentiation by targeting forkhead box O1 (Foxo1) and is associated with inflammatory bowel disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2018.01.055"}], "href": "https://doi.org/10.1016/j.bbrc.2018.01.055"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29331376"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29331376"}]}]}]}
|
| Synonyms | MIR-425, MIRN425, HSA-MIR-425 |
| NCBI Gene ID | 494337 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR425 has 1,701 functional associations with biological entities spanning 6 categories (molecular profile, disease, phenotype or trait, functional term, phrase or reference, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 17 datasets.
Click the + buttons to view associations for MIR425 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR425 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR425 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MIR425 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR425 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| CTD Gene-Disease Associations | diseases associated with MIR425 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR425 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR425 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR425 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MIR425 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing MIR425 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MIR425 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MIR425 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of MIR425 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR425 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by MIR425 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR425 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR425 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |